Hyalovet
Loading...Hyalovet Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Do not use in horses intended for human consumption. Not for human use. Hyalovet Injection must not be administered intravascularly.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
There is currently no usage information available for this product. We apologize for any inconvenience.
History
There is currently no drug history available for this drug.
Other Information
Hyaluronic acid is the prototype of a wide range of saccharide biopolymers (glycosaminoglycans or mucopolysaccharides) consisting of repeating disaccharide units of N-acetyl-D-glucosamine and D-glucuronic acid linked by beta 1-3 and beta 1-4 glycosidic bonds. A component of all mammalian connective tissue, hyaluronic acid confers viscoelastic and lubricating properties to synovial fluid1 and structural integrity to cartilage matrix2. As a therapeutic agent, hyaluronic acid injected into arthritic joints has been shown, in a variety of animal model systems including horses3, to improve joint function and to activate tissue repair processes in articular cartilage.
Hyalovet (hyaluronate sodium) is clear, colorless, viscous solution of a specific fraction of highly purified hyaluronic acid obtained by a molecular filtration procedure from biological material (rooster combs). The specific hyaluronic acid fraction from which Hyalovet is made has a high degree of molecular definition with an average molecular weight of 500,000-730,000 D.
Each filled 2 mL glass syringe or 2 mL glass vial contains:
Hyaluronate sodium........................................20.0 mg
Sodium chloride..............................................17.0 mg
Monobasic sodium phosphate...........................0.1 mg
Dibasic sodium phosphate.................................1.2 mg
Water for injection.......................................q.s., 2 mL
Sources
Hyalovet Manufacturers
-
Boehringer Ingelheim Vetmedica, Inc.
![Hyalovet (Hyaluronate Sodium) Liquid [Boehringer Ingelheim Vetmedica, Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Hyalovet | Boehringer Ingelheim Vetmedica, Inc.
The recommended dose of Hyalovet (hyaluronate sodium) is 2 mL (20 mg hyaluronate sodium) in small or medium sized joints (carpus, fetlock) given by intra-articular injection. More than one joint may be treated at the same time. If necessary, the injection may be repeated after one or more weeks, but not to exceed 2 injections per week for a total of 4 weeks.
Hyalovet should be injected using strict aseptic technique. Excess synovial fluid should be removed prior to injection.
For best results horses should be given two days of rest or limited exercise before resuming normal training.
Login To Your Free Account